Evidence map›Paper›PMID 25392483›Full record

ReviewThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Baths salts, spice, and related designer drugs: the science behind the headlines.

Michael H Baumann, Ernesto Solis, Lucas R Watterson, Julie A Marusich, William E Fantegrossi, Jenny L Wiley

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 153 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Michael H BaumannDesigner Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, mbaumann@mail.nih.gov.
Ernesto SolisDepartment of Physiology & Biophysics, Virginia Commonwealth University School of Medicine, Richmond, Virginia 23298.
Lucas R WattersonDepartment of Psychology, Behavioral Neuroscience Area, Arizona State University, Tempe, Arizona 85287.ORCID http://orcid.org/0000-0002-9436-2840
Julie A MarusichRTI International, Research Triangle Park, North Carolina 27709, and.
William E FantegrossiDepartment of Pharmacology & Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205.
Jenny L WileyRTI International, Research Triangle Park, North Carolina 27709, and.
RTI International · USArizona State University · USNational Institute on Drug Abuse · USUniversity of Arkansas for Medical Sciences · USVirginia Commonwealth University · US

Funding

THC RECEPTORSR01DA003672 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI WILEY, JENNY L. · 1985 to 2018
$4.9M
NIDA NIH HHS R01 DA003672
6 · The paper itself

Abstract

The abuse of synthetic psychoactive substances known as "designer drugs," or "new psychoactive substances" (NPS), is increasing at an alarming rate. NPS are purchased as alternatives to traditional illicit drugs of abuse and are manufactured to circumvent laws regulating the sale and use of controlled substances. Synthetic cathinones (i.e., "bath salts") and synthetic cannabinoids (i.e., "spice") are two types of NPS that have received substantial media attention. Although low recreational doses of bath salts or spice compounds can produce desirable effects, high doses or chronic exposure often leads to dangerous medical consequences, including psychosis, violent behaviors, tachycardia, hyperthermia, and even death. Despite the popularity of NPS, there is a paucity of scientific data about these drugs. Here we provide a brief up-to-date review describing the mechanisms of action and neurobiological effects of synthetic cathinones and cannabinoids.

Indexed as

AlkaloidsAnimalsCannabinoidsCentral Nervous System StimulantsDesigner DrugsIllicit DrugsMethamphetamineMolecular StructureReceptors, CannabinoidVesicular Monoamine Transport ProteinsAlkaloidsCannabinoidsCentral Nervous System StimulantsDesigner DrugsIllicit DrugsMethamphetamineReceptors, CannabinoidVesicular Monoamine Transport Proteins

Identifiers

PMID25392483
PMCPMC4228124
OpenAlexW2068247023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.